ECCMID 2023: Shionogi Announces Real-World Evidence …
https://www.shionogi.com/us/en/news/2023/04/eccmid-2023-shionogi-announces-real-world-evidence-demonstrating-the-efficacy-of-fetcroja-fetroja-cefiderocol-against-some-of-the-most-difficult-to-treat-gram-negative-bacterial-pathogens.html
WebApr 17, 2023 · Fetroja® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, …
DA: 48 PA: 63 MOZ Rank: 62 Up or Down: Up